Avricore Health Inc. (TSXV:AVCR)
Canada
· Delayed Price · Currency is CAD 0.0550
0.00 (0.00%)
Apr 23, 2025, 12:23 PM EDT
Avricore Health Income Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2014 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2014 - 2018 |
| Revenue | 4.72 | 3.49 | 1.77 | 0.12 | 0.03 | 0.03 | Upgrade
|
| Revenue Growth (YoY) | 51.84% | 97.08% | 1339.95% | 271.81% | 0.09% | 115.76% | Upgrade
|
| Cost of Revenue | 2.93 | 2.28 | 1.31 | 0.09 | 0.2 | 0.02 | Upgrade
|
| Gross Profit | 1.79 | 1.2 | 0.46 | 0.03 | -0.16 | 0.01 | Upgrade
|
| Selling, General & Admin | 1.1 | 1.08 | 0.77 | 0.93 | 0.76 | 1.35 | Upgrade
|
| Operating Expenses | 1.62 | 1.79 | 1.11 | 1.45 | 0.89 | 1.62 | Upgrade
|
| Operating Income | 0.17 | -0.59 | -0.65 | -1.42 | -1.05 | -1.6 | Upgrade
|
| Interest Expense | - | - | - | -0.04 | -0.14 | -0.01 | Upgrade
|
| Interest & Investment Income | 0 | 0 | 0.01 | 0 | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | -0.01 | -0.01 | 0 | -0 | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | -0.07 | -0.11 | -0.17 | -0.33 | -0.02 | 0 | Upgrade
|
| EBT Excluding Unusual Items | 0.09 | -0.7 | -0.82 | -1.78 | -1.21 | -1.61 | Upgrade
|
| Asset Writedown | - | - | - | - | - | -0.31 | Upgrade
|
| Other Unusual Items | 0.01 | - | - | 0.08 | 0.03 | 0 | Upgrade
|
| Pretax Income | 0.1 | -0.7 | -0.82 | -1.71 | -1.17 | -1.92 | Upgrade
|
| Earnings From Continuing Operations | 0.1 | -0.7 | -0.82 | -1.71 | -1.17 | -1.92 | Upgrade
|
| Earnings From Discontinued Operations | - | - | - | - | - | -0.19 | Upgrade
|
| Net Income | 0.1 | -0.7 | -0.82 | -1.71 | -1.17 | -2.11 | Upgrade
|
| Net Income to Common | 0.1 | -0.7 | -0.82 | -1.71 | -1.17 | -2.11 | Upgrade
|
| Shares Outstanding (Basic) | 100 | 100 | 98 | 93 | 60 | 47 | Upgrade
|
| Shares Outstanding (Diluted) | 103 | 100 | 98 | 93 | 60 | 47 | Upgrade
|
| Shares Change (YoY) | 4.23% | 1.74% | 5.67% | 53.20% | 27.82% | 39.63% | Upgrade
|
| EPS (Basic) | 0.00 | -0.01 | -0.01 | -0.02 | -0.02 | -0.04 | Upgrade
|
| EPS (Diluted) | 0.00 | -0.01 | -0.01 | -0.02 | -0.02 | -0.04 | Upgrade
|
| Free Cash Flow | 0.39 | -0.36 | -1.63 | -1.34 | -1.22 | -0.69 | Upgrade
|
| Free Cash Flow Per Share | 0.00 | -0.00 | -0.02 | -0.01 | -0.02 | -0.01 | Upgrade
|
| Gross Margin | 37.97% | 34.53% | 25.83% | 24.85% | - | 43.93% | Upgrade
|
| Operating Margin | 3.62% | -16.80% | -36.96% | -1153.22% | -3175.64% | -4858.04% | Upgrade
|
| Profit Margin | 2.19% | -20.12% | -46.27% | -1390.90% | -3554.24% | -6380.63% | Upgrade
|
| Free Cash Flow Margin | 8.20% | -10.36% | -92.24% | -1090.74% | -3703.89% | -2080.02% | Upgrade
|
| EBITDA | 0.62 | -0.17 | -0.48 | -1.4 | -0.93 | -1.48 | Upgrade
|
| EBITDA Margin | 13.21% | -4.99% | -26.99% | - | - | - | Upgrade
|
| D&A For EBITDA | 0.45 | 0.41 | 0.18 | 0.02 | 0.12 | 0.12 | Upgrade
|
| EBIT | 0.17 | -0.59 | -0.65 | -1.42 | -1.05 | -1.6 | Upgrade
|
| EBIT Margin | 3.62% | -16.80% | -36.96% | - | - | - | Upgrade
|
| Advertising Expenses | - | 0 | 0 | - | - | - | Upgrade
|
Updated Nov 29, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.